BMEA

Biomea Fusion Inc

NASDAQ: BMEA · HEALTHCARE · BIOTECHNOLOGY

$1.43

-5.11% today

Updated 2026-06-03

Market cap

$99.05M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.55

Dividend yield

—

52W range

$1 – $3

Volume

1.6M

Market cap

$99.05M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.55

Dividend yield

—

52W range

$1 – $3

Volume

1.6M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.5

Quality

3.0

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

-13.7

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$6.83

+377.62%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

2 Strong Buy4 Buy0 Hold0 Sell1 Strong Sell

Price chart

Stock snapshot

Strengths

+ Debt/equity 0.07x — low leverage

Risks

- Piotroski 3/9 — weak financial health

- Altman Z -13.74 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-11.67M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-80.02M	$-117.25M	$-138.43M	$-61.80M	$-12.41M
EPS	—	—	—	—	$-0.55
Free cash flow	$-63.45M	$-99.96M	$-120.26M	$-70.37M	$-11.67M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
BMEA	$99.05M	19	4.3	3.0	5.0	6.5	—	Avoid
LLY	$948.95B	78	10.0	10.0	5.0	6.0	—	Strong Buy
JNJ	$536.54B	59	4.7	9.0	3.3	6.0	-71.41%	Buy
ABBV	$380.57B	63	4.0	8.0	4.0	5.0	-55.64%	Buy
UNH	$343.21B	54	5.3	5.5	4.7	5.5	-26.61%	Buy
MRK	$285.64B	50	3.3	8.0	2.7	5.0	-49.34%	Hold

Smart narrative

Biomea Fusion Inc trades at $1.43. Our Smart Value Score of 19/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -13.74, it sits in the distress.

Frequently asked questions

What is Biomea Fusion Inc's stock price?

Biomea Fusion Inc (BMEA) trades at $1.43.

Is Biomea Fusion Inc overvalued?

Biomea Fusion Inc carries a Smart Value Score of 19/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Biomea Fusion Inc (BMEA)?

The 12-month analyst consensus target is $6.83, about 377.6% above the current $1.43. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Altman Z-Score?

Biomea Fusion Inc's Altman Z-Score is -13.74, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-189.40%

Beta-0.34

50D MA$1.56

200D MA$1.50

Shares out0.07B

Float0.07B

Short ratio—

Avg volume1.6M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

BMEA vs LLY →BMEA vs JNJ →BMEA vs ABBV →Stock screener →